Editas Medicine, Inc. (EDIT) RBC Capital Markets Global Healthcare Conference (Transcript)Seeking Alpha • 05/16/24
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in JuneGlobeNewsWire • 05/14/24
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingGlobeNewsWire • 05/10/24
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?The Motley Fool • 05/09/24
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsGlobeNewsWire • 05/02/24
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationGlobeNewsWire • 05/01/24
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/26/24
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingGlobeNewsWire • 04/22/24
Editas Medicine, Inc. (EDIT) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 03/13/24
Editas Medicine, Inc. (EDIT) Leerink Partners Global Biopharma Conference (Transcript)Seeking Alpha • 03/12/24
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.The Motley Fool • 03/07/24
Editas Medicine, Inc. (EDIT) TD Cowen 44th Annual Healthcare Conference (Transcript)Seeking Alpha • 03/06/24
Editas Medicine: Several Catalysts For Reni-Cel In 2024 Make This A Must WatchSeeking Alpha • 02/28/24
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business UpdatesGlobeNewsWire • 02/28/24
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor EventsGlobeNewsWire • 02/21/24
Wall Street Analysts Believe Editas (EDIT) Could Rally 80%: Here's is How to TradeZacks Investment Research • 02/19/24
Editas Medicine, Inc. (EDIT) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)Seeking Alpha • 02/13/24